So not only did we not get a BLA resubmission announcement from the company by 30 June as touted by SI (may still come this morning) we also didn't receive confirmation that the first patient was in fact dosed in the Rexlemestrocel-L CLBP trial either and of course it still shows as 'Not Yet Recruiting' on the FDA clinical trials website.....
...... and people wonder why LT shareholders get annoyed with the CEO spruiking stuff through the various media avenues that don't come to fruition within the guidelines the company sets..... and as I have stated previously, the new Chairperson (JB) is complicit in this rhetoric no matter how much you defend her ?
https://clinicaltrials.gov/study/NCT06325566?intr=Rexlemestrocel-L&rank=3
banter and General Discussion, page-9986
-
- There are more pages in this discussion • 325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |